Gemcitabine plus Oxaliplatin (GEMOXI): a feasible treatment in elderly patients with advanced pancreatic cancer

被引：0
|
作者：
Corradini, G. M. [1 ]
Candido, P. [1 ]
Della Torre, S. [1 ]
Zannier, F. [1 ]
Cozzi, C. [1 ]
Belloni, P. [1 ]
Toniolo, D. [1 ]
Bollina, R. [1 ]
Tagliaferro, G. [1 ]
机构：
[1] Azienda Osped G Salvini, Div Med Oncol, Rho, Italy
来源：
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY | 2009年 / 72卷
关键词：
D O I：
10.1016/S1040-8428(09)70146-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S56 / S57
页数：2
相关论文
共 50 条
  • [21] Maintenance treatment with gemcitabine after gemcitabine plus Nab-paclitaxel in advanced pancreatic cancer
    Kodama, Tomoko
    Nakazawa, Junichi
    Kawahira, Masahiro
    Ymasuji, Akihiro
    Iwashita, Yuji
    Hori, Takeshi
    Kawahira, Machiko
    Arima, Shiho
    Tubouchi, Hirohito
    Ido, Akio
    ANNALS OF ONCOLOGY, 2022, 33 : S484 - S484
  • [22] Hypofractionated Chemoradiation Therapy With Gemcitabine Plus Oxaliplatin for Unresectable Nonmetastatic Locally-Advanced Pancreatic Cancer
    Romeo, A.
    Parisi, E.
    Passardi, A.
    Bellia, S.
    Arpa, D.
    Ghigi, G.
    Neri, E.
    Sarnelli, A.
    Tesei, A.
    Polico, R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S307 - S307
  • [23] Capecitabine plus oxaliplatin (CapOx) versus capecitabine plus gemcitabine (CapGem) versus gemcitabine plus oxaliplatin (mGemOx): final results of a multicenter randomized phase II trial in advanced pancreatic cancer
    Boeck, S.
    Hoehler, T.
    Seipelt, G.
    Mahlberg, R.
    Wein, A.
    Hochhaus, A.
    Boeck, H. -P.
    Schmid, B.
    Kettner, E.
    Stauchlo, M.
    Lordick, F.
    Ko, Y.
    Geissler, M.
    Schoppmeyer, K.
    Kojouharoff, G.
    Golf, A.
    Neugebauer, S.
    Heinemann, V.
    ANNALS OF ONCOLOGY, 2008, 19 (02) : 340 - 347
  • [24] Gemcitabine plus cisplatin in advanced pancreatic cancer - Reply
    Heinemann, Volker
    Boeck, Stefan
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (09) : 1142 - 1143
  • [25] Gemcitabine plus capecitabine is effective in advanced pancreatic cancer
    Nature Clinical Practice Oncology, 2007, 4 (9): : 504 - 504
  • [26] Tolerance and efficacy of gemcitabine and gemcitabine-based regimens in elderly patients with advanced pancreatic cancer
    Marechal, Raphael
    Demols, Anne
    Gay, France
    de Maertelaer, Viviane
    Arvanitaki, Marianna
    Hendlisz, Alain
    Van Laethem, Jean-Luc
    PANCREAS, 2008, 36 (03) : E16 - E21
  • [27] Gemcitabine and oxaliplatin for patients with advanced or metastatic pancreatic cancer: a North Central Cancer Treatment Group (NCCTG) phase I study
    Alberts, SR
    Townley, PM
    Goldberg, RM
    Cha, SS
    Moore, DF
    Krook, JE
    Pitot, HC
    Fitch, TR
    Wiesenfeld, M
    Mailliard, JA
    Sargent, DJ
    ANNALS OF ONCOLOGY, 2002, 13 (04) : 553 - 557
  • [28] Efficacy of nimotuzumab plus gemcitabine usage as first-line treatment in patients with advanced pancreatic cancer
    Su, Dan
    Jiao, Shun-Chang
    Wang, Li-Jie
    Shi, Wei-Wei
    Long, Yan-Yan
    Li, Juan
    Bai, Li
    TUMOR BIOLOGY, 2014, 35 (03) : 2313 - 2318
  • [29] Gemcitabine (GEM) plus oxaliplatin (LOHP) as salvage treatment in anthracycline and taxane pretreated patients with advanced breast cancer (ABC)
    Kalikaki, A.
    Potamianou, A.
    Malamos, N.
    Syrigos, K.
    Kalbakis, K.
    Androulakis, N.
    Vamvakas, L.
    Bozionelou, V.
    Kotsakis, A.
    Mavroudis, D.
    EJC SUPPLEMENTS, 2005, 3 (02): : 129 - 130
  • [30] A Phase II Trial of Gemcitabine plus Capecitabine for Patients with Advanced Pancreatic Cancer
    Choi, Jong Gwon
    Seo, Jae Hong
    Oh, Sang Cheul
    Choi, Chul Won
    Kim, Jun Suk
    CANCER RESEARCH AND TREATMENT, 2012, 44 (02): : 127 - 132
12345